UP!

UNH $493.1

UNH target price
493.10
255
650
UnitedHealth Group Inc.
Type
Public
Traded as NYSE: UNH
DJIA component
S&P 100 component
S&P 500 component
Industry Managed health care
Founded 1977; 40 years ago (1977)
Founder Richard T. Burke
Headquarters Minnetonka, Minnesota, U.S.
Key people
Richard T. Burke (Chairman)
Dave Wichmann (CEO)
Products Uniprise, Health Care Services, Specialized Care Services, and Ingenix
Revenue IncreaseUS$184.8 billion (2016)
Operating income
IncreaseUS$12.93 billion (2016)
Net income
IncreaseUS$7.01 billion (2016)
Total assets IncreaseUS$122.8 billion (2016)
Total equity IncreaseUS$38.27 billion (2016)
Number of employees
230,000 (2016)
Website www.unitedhealthgroup.com

UnitedHealth Group Inc. is an American profit managed health care company based in Minnetonka, Minnesota. It is sixth in the United States on the Fortune 500. UnitedHealth Group offers health care products and insurance services. UnitedHealth Group is the largest healthcare company in the world by revenue $184 billion in 2016. UnitedHealth Group subsidiaries companies together serves approximately 115 million individuals in 2016.

In 2011, J.D. Power and Associates gave UnitedHealthcare the highest employer satisfaction rating for self-insured health plans. In a 2010 insurance industry publication, Business Insurance (magazine), UnitedHealthcare was named "Readers Choice" winner in 2010 for "Best health plan provider". In 2016, Optum was named "North America Company of the Year for Population Health Management" by Frost & Sullivan

Beginning in 2011 and continuing into 2012, UnitedHealth Group implemented an enterprise reorganization. This coincided with retiring brands adopted following the various acquisitions of previous years and adopting the unified brand UnitedHealthcare. The firm decided to refocus its UK business solely on commissioning support under the name of Optum, and exploit the opportunities presented by the United Kingdom Government's NHS reforms in 2011. Towards this end, it sold its six primary care clinics.

Optum includes three divisions:

In addition, there are two shared service functions under Optum: Optum Technology and Optum Operations.

UnitedHealthcare includes four divisions:

In 1974, Richard Taylor Burke founded Charter Med Incorporated, a Minnetonka, Minnesota-based privately held company. In 1977, UnitedHealthCare Corporation was created to reorganize the company and become the parent company of Charter Med. UnitedHealthCare’s charter was to manage the newly created Physicians Health Plan of Minnesota, an early health management organization.

In 1994, UnitedHealth sold its pharmacy benefit manager, Diversified Pharmaceutical Services, to SmithKline Beecham for $2.3 billion. Also in 1994, UnitedHealth acquired Ramsey-HMO, a Florida insurer.

In 1995, the company acquired The MetraHealth Companies Inc. for $1.65 billion. MetraHealth was a privately held company formed by combining the group health care operations of The Travelers Insurance Company and Metropolitan Life Insurance Company also known as MetLife.

In 1996, United HealthCare acquired HealthWise of America, which operated HMOs in Arkansas, Maryland, Kentucky and Tennessee.

In 1998, UnitedHealth Group acquired HealthPartners of Arizona, operator of Arizona's largest AHCCCS provider.

In 2001, EverCare, a UnitedHealth Group subsidiary merged with LifeMark Health Plans

In 2002, UnitedHealth Group acquired Medicaid insurance company AmeriChoice.

In 2003, UnitedHealth Group acquired Mid Atlantic Medical Services, an insurer serving Maryland, Washington D.C., Virginia, Delaware and West Virginia. Also in 2003, UnitedHealth Group acquired Golden Rule Financial, a provider of health savings accounts.

Optum Bank started operating on July 21, 2003, in Salt Lake City, Utah, as a Utah state-chartered industrial loan corporation. Originally named Exante Bank, it changed its name to OptumHealth Bank in 2008 and to Optum Bank in 2012. Optum Bank is part of the financial services unit of Optum a health and wellness company serving more than 74 million people. Optum is part of the UnitedHealth Group family of companies.

In April 2004, UnitedHealth Group acquired Touchpoint Health Plan, a Wisconsin health plan. In July 2004, UnitedHealth Group acquired Oxford Health Plans and all of UnitedHealthcare's New York-based small group contracts are now Oxford Health Plans products.

In December 2005, the company received final regulatory approval for its $9.2 billion purchase of PacifiCare Health Systems. It agreed to divest parts of PacifiCare's commercial health insurance business in Tucson, Arizona and Boulder, Colorado to satisfy antitrust regulator concerns, and also agreed to end its network access agreement with Blue Shield of California. The Tucson business was sold to Cigna. Also in December 2005, UnitedHealth Group acquired John Deere Health Care.

In March 2007, UnitedHealth Group signed a definitive agreement to acquire Sierra Health Services Inc. for $2.6 billion. Sierra provided health benefits and services to 310,000 members in Nevada and another 320,000 people in senior and government programs throughout the United States. As a condition of approval from the Department of Justice, UnitedHealth Group was required to divest its individual SecureHorizons Medicare Advantage HMO plans in Clark and Nye Counties, which represent approximately 25,000 members. UnitedHealth Group reached an agreement to transition these members to Humana Inc., subject to customary closing conditions.

In July 2009, UnitedHealth Group agreed to acquire Health Net's Northeast licensed subsidiaries for up to $570 million in payments spread out over two years.

In July 2010, Ingenix acquired Picis, a health information provider for the high-acuity areas of hospitals.

In 2011, Logistics Health, Inc. of La Crosse, Wisconsin, was acquired by OptumHealth In September 2014 the office buildings where LHI is based were sold to UnitedHealth Group for $45 million.

In February 2012, UnitedHealth Group completed the acquisition of XLHealth, a sponsor of Medicare Advantage health plans with a primary focus on medicare recipients with special needs such as those with chronic illness and those eligible for Medicaid ("dual eligibles").

In October 2012, UnitedHealth Group and Amil Participações, one of the biggest Brazilian health insurance companies, completed the first phase of their merger.

In March 2015, it was announced that CatamaranRx will be acquired by OptumRx (A UnitedHealth Group company).

In February 2017, UnitedHealth completed acquisition of Rally Health Inc.

In 2010, UnitedHealth Group spent more than $1.8 million on lobbying activities to work to achieve favorable legislation, and hired seven different lobbying firms to work on its behalf. In addition, its corporate political action committee or PAC, called United for Health, spent an additional $1 million on lobbying activities in 2010.

QSSI, a subsidiary of UnitedHealth Group, is one of the 55 contractors hired by United States Department of Health and Human Services to work on the HealthCare.gov web site

Through 2010 and into 2011, UnitedHealth senior executives have been meeting monthly with executives of leading health insurers to limit the effect of the health care reform law.

In April 2016, UnitedHealth announced it was pulling out of all but a "handful" of state healthcare exchanges provided under ACA and will continue to sell only in three states in 2017.

In 2006, the Securities and Exchange Commission (SEC) began investigating the conduct of UnitedHealth Group's management and directors, for backdating of stock options. Investigations were also begun by the Internal Revenue Service and prosecutors in the U.S. attorney's office for the Southern District of New York, who subpoenaed documents from the company. The investigations came to light after a series of probing stories in the Wall Street Journal in May 2006, discussing apparent backdating of hundreds of millions of dollars' worth of stock options by UHC management. The backdating apparently occurred with the knowledge and approval of the directors, according to the Journal. Major shareholders have filed lawsuits accusing former New Jersey governor Thomas Kean and UHC's other directors of failing in their fiduciary duty. On October 15, 2006, CEO William W. McGuire was forced to resign, and relinquish hundreds of millions of dollars in stock options. On December 6, 2007, the SEC announced a settlement under which McGuire will repay $468 million, as a partial settlement of the backdating prosecution. Legal actions filed by the SEC against UnitedHealth Group itself are still pending.

In June 2006, the American Chiropractic Association filed a national class action lawsuit against the American Chiropractic Network (ACN), which is owned by UnitedHealth Group and administers chiropractic benefits, and against UnitedHealth Group itself, for alleged practices in violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO).

In February 2008, New York State Attorney General Andrew M. Cuomo announced an industry-wide investigation into a scheme by health insurers to defraud consumers by manipulating reasonable and customary rates. The announcement included a statement that Cuomo intended "to file suit against Ingenix, Inc., its parent UnitedHealth Group, and three additional subsidiaries." Cuomo asserted that his investigation found that rates found in a database of health care charges maintained by Ingenix were lower than what he determined was the actual cost of certain medical expenses. Cuomo said this inappropriately allowed health insurance companies to deny a portion of provider claims, thereby pushing costs down to members.

On January 13, 2009, Ingenix announced an agreement with the New York State attorney settling the probe into the independence of the health pricing database. Under the settlement, UnitedHealth Group and Ingenix would pay $50 million to finance a new, non-profit entity that would develop a new health care pricing database. Ingenix would discontinue its medical pricing databases when the new entity makes its product available. The company acknowledged the appearance of a conflict of interest, but admitted no wrongdoing.

On January 15, 2009, UnitedHealth Group announced a $350 million settlement of three class action lawsuits filed in Federal court by the American Medical Association, UnitedHealth Group members, healthcare providers, and state medical societies for not paying out-of-network benefits. This settlement came two days after a similar settlement with Cuomo.

On October 27, 2009, Cuomo announced the creation of FAIR Health, the independent, non-profit organization that will develop a nationwide database for consumer reimbursement, as well as a website where consumers will be able to compare prices before they choose doctors. To fund FAIR Health, the Attorney General's office secured nearly $100 million from insurers such as Aetna, UnitedHealth Group, and Anthem.

In 2006, the SEC began investigating the conduct of UnitedHealth Group's management and directors, including Dr. McGuire, as did the Internal Revenue Service and prosecutors in the U.S. attorney's office for the Southern District of New York, who have subpoenaed documents from the company.

The investigations came to light after a series of probing stories in the Wall Street Journal in March 2006, discussing the apparent backdating of hundreds of millions of dollars' worth of stock options—in a process called options backdating—by UnitedHealth Group management. The backdating apparently occurred with the knowledge and approval of the directors, according to the Journal. Major shareholders have filed lawsuits accusing former New Jersey governor Thomas Kean and UnitedHealth Group's other directors of failing in their fiduciary duty.

On October 15, 2006, it was announced that Dr. McGuire would step down immediately as chairman and director of UnitedHealth Group, and step down as CEO on December 1, 2006, due to his involvement in the employee stock options scandal. Simultaneously, it was announced that he would be replaced as CEO by Stephen Hemsley, who has served as President and COO and is a member of the board of directors. McGuire's exit compensation from UnitedHealth, expected to be around $1.1 billion, would be the largest golden parachute in the history of corporate America.

McGuire's compensation became controversial again on May 21, 2009, when Elizabeth Edwards, speaking on The Daily Show, used it to support her argument for a public alternative to commercial insurance. Edwards stressed the importance of restoring competition in health insurance markets noting that at one point, "the President of UnitedHealth made so much money, that one of every $700 that was spent in this country on health care went to pay him." Since estimates of McGuire's 2005 compensation range from $59,625,444 to $124.8 million, and the revenue of UnitedHealth Group was then $71 billion, it is therefore possible that Mrs. Edwards may have meant that one of every $700 that was spent on UnitedHealth Group premiums went to pay McGuire.

On December 6, 2007, the SEC announced a settlement under which McGuire was to repay $468 million, including a $7 million civil penalty, as a partial settlement of the backdating prosecution. He was also barred from serving as an officer or director of a public company for ten years. This was the first time in which the little-used "clawback" provision under the Sarbanes-Oxley Act was used against an individual by the SEC. The SEC continued its investigations even after it in 2008 settled legal actions against both UnitedHealth Group itself and its former general counsel.

A whistleblower lawsuit, filed in 2011, charges UnitedHealth Group's data analytics division with assisting in defrauding Medicare by boosting risk adjustment scores from Medicare Advantage companies. The suit alleges that UnitedHealth Group subsidiary Ingenix (now OptumInsight) "defrauded the United States of hundreds of millions — and likely billions — of dollars." Former UnitedHealth executive Benjamin Poehling brought the suit under the False Claims Act. The government said it would proceed on claims against two health care companies, UnitedHealth and its Texas subsidiary WellMed Medical Management. In February 2017, a federal judge unsealed the suit after the Department of Justice announced it would join the case.

The Lewin Group is a policy research and consulting firm that provides economic analysis of health care and human services issues and policies. The organization has existed for about 40 years and has maintained a nonpartisan reputation through its many ownership changes that have occurred over that time. The Lewin Group was purchased in 2007 by Ingenix, a subsidiary of UnitedHealth Group, but alleges editorial and analytical "independence" from UnitedHealth Group, its parent company. The Lewin Group discloses its ownership in its reports and on its web site. While the Lewin Group does not advocate for or against any legislation, both Democratic and Republican politicians frequently cite the firm's studies to argue for and against various U.S. healthcare reform proposals. For example, Democratic Senator Ron Wyden uses Lewin Group estimates to cite the feasibility of his Healthy Americans Act. Representative Eric Cantor, the House Republican Whip, has referred to the organization as "the nonpartisan Lewin Group" in arguing against government-funded health insurance proposals. Recently, several Lewin studies have been used to argue both for and against the inclusion of a public option in national health reform. Lewin clients who often cite its findings include The Commonwealth Fund which recently held up a Lewin study it commissioned to advocate for a public plan. The report showed that legislative proposals would achieve nearly universal coverage and "estimated that a public plan could offer small businesses insurance that is at least 9 percent cheaper than current small-business policies." However, The Lewin Group has acknowledged that clients sometimes choose not to publicize the results of studies they have commissioned. Indeed, Lewin Group Vice President John Sheils told the Washington Post "sometimes studies come out that don't show exactly what the client wants to see. And in those instances, they have [the] option to bury the study."

UnitedHealth Group has two foundations, the UnitedHealth Foundation and UnitedHealthcare Children’s Foundation which were formed in 1999. Since established by UnitedHealth Group in 1999 as a not for profit private foundation, the UnitedHealth Foundation has committed more than $170 million to improve health and health care.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2023 2023-07-14 Future report Set alerts
Q4 2022 2023-01-13 5.34 5.34
Q3 2022 2022-10-14 5.79 5.79
Q2 2022 2022-07-15 5.57 5.57
Q1 2022 2022-04-14 5.49 5.49
Q4 2021 2022-01-19 4.48 4.48
Q3 2021 2021-10-14 4.52 4.52
Q2 2021 2021-07-15 4.70 4.70
Q1 2021 2021-04-15 5.31 5.31
Q4 2020 2021-01-20 2.52 2.52

Ratings

2016-06-29 Reiterated Rating Credit Suisse Buy $148.00
2016-06-29 Reiterated Rating Credit Suisse Group AG Buy $148.00
2016-06-28 Initiated Coverage Wolfe Research Outperform $172.00
2016-06-27 Reiterated Rating Leerink Swann Buy
2016-06-15 Initiated Coverage Sanford C. Bernstein Outperform $171.00
2016-06-10 Reiterated Rating Credit Suisse Buy
2016-06-10 Reiterated Rating Leerink Swann Buy
2016-05-18 Reiterated Rating Credit Suisse Buy
2016-05-18 Reiterated Rating Morgan Stanley Buy
2016-05-17 Reiterated Rating Jefferies Group Buy $153.00
2016-04-20 Boost Price Target Mizuho Buy $150.00 to $156.00
2016-04-20 Reiterated Rating FBR & Co. Buy
2016-04-20 Reiterated Rating FBR & Co Buy
2016-04-19 Reiterated Rating Wedbush Outperform $138.00
2016-04-19 Boost Price Target FBR & Co. Outperform $130.00 to $145.00
2016-04-19 Reiterated Rating Leerink Swann Outperform $150.00
2016-04-14 Reiterated Rating FBR & Co. Outperform $130.00 to $145.00
2016-04-08 Initiated Coverage Cleveland Research Buy $155.00
2016-04-05 Reiterated Rating Cowen and Company Outperform
2016-03-17 Reiterated Rating FBR & Co. Outperform
2016-03-14 Boost Price Target Mizuho Buy $131.00 to $150.00
2016-03-06 Reiterated Rating Credit Suisse Buy
2016-03-03 Boost Price Target Credit Suisse Outperform $133.00 to $138.00
2016-02-16 Reiterated Rating Piper Jaffray Overweight $142.00
2016-02-16 Reiterated Rating Piper Jaffray Cos. Overweight $142.00
2016-02-09 Reiterated Rating Cowen and Company Buy
2016-02-09 Lower Price Target Goldman Sachs $130.00 to $124.00
2016-02-09 Lower Price Target Goldman Sachs Group Inc. $130.00 to $124.00
2016-01-20 Reiterated Rating Piper Jaffray Overweight $149.00 to $142.00
2016-01-20 Reiterated Rating FBR & Co. Outperform $130.00
2016-01-20 Boost Price Target Jefferies Group Buy $135.00 to $136.00
2016-01-19 Reiterated Rating Wedbush Outperform $138.00
2016-01-15 Reiterated Rating Cowen and Company Buy
2016-01-08 Reiterated Rating Jefferies Group Buy $142.00 to $135.00
2015-12-17 Reiterated Rating Credit Suisse Buy
2015-12-16 Initiated Coverage Credit Suisse Outperform $133.00
2015-12-02 Reiterated Rating Susquehanna Positive $150.00
2015-12-02 Reiterated Rating Stifel Nicolaus Buy $148.00
2015-12-02 Reiterated Rating Oppenheimer Outperform $140.00
2015-12-02 Boost Price Target BMO Capital Markets Outperform $130.00 to $138.00
2015-12-02 Reiterated Rating Oppenheimer Holdings Inc. Outperform $140.00
2015-11-22 Reiterated Rating Leerink Swann Buy $150.00
2015-11-22 Reiterated Rating Cantor Fitzgerald Hold $135.00
2015-11-20 Lower Price Target Raymond James Strong-Buy $146.00 to $140.00
2015-11-20 Lower Price Target JPMorgan Chase & Co. Overweight $150.00 to $140.00
2015-11-20 Lower Price Target Jefferies Group Buy $142.00
2015-11-20 Lower Price Target BMO Capital Markets $139.00 to $130.00
2015-11-20 Lower Price Target Mizuho Buy $155.00 to $131.00
2015-11-20 Lower Price Target Raymond James Financial Inc. Strong-Buy $146.00 to $140.00
2015-11-19 Lower Price Target FBR & Co. Outperform $135.00 to $130.00
2015-10-19 Reiterated Rating Leerink Swann Buy
2015-10-16 Lower Price Target Leerink Swann Outperform $160.00 to $150.00
2015-10-16 Reiterated Rating Susquehanna Buy
2015-10-15 Reiterated Rating FBR & Co. Buy $135.00
2015-10-06 Reiterated Rating Mizuho Buy $150.00
2015-10-02 Initiated Coverage Citigroup Inc. Buy $133.00
2015-09-21 Reiterated Rating FBR & Co. Buy $135.00
2015-09-16 Initiated Coverage JPMorgan Chase & Co. Overweight $150.00
2015-09-09 Initiated Coverage Morgan Stanley Overweight $140.00
2015-07-20 Boost Price Target RBC Capital Outperform $159.00 to $166.00
2015-07-20 Boost Price Target Barclays Overweight $140.00 to $142.00
2015-07-20 Boost Price Target Royal Bank Of Canada Outperform $159.00 to $166.00
2015-07-20 Boost Price Target Barclays PLC Overweight $140.00 to $142.00
2015-07-17 Boost Price Target Leerink Swann Outperform $155.00 to $160.00
2015-07-17 Boost Price Target Wedbush Outperform $138.00 to $143.00
2015-07-17 Boost Price Target Oppenheimer Outperform $133.00 to $140.00
2015-07-17 Reiterated Rating Cantor Fitzgerald Hold $135.00
2015-07-16 Reiterated Rating Mizuho Buy $146.00 to $150.00
2015-06-26 Upgrade Sterne Agee CRT Neutral to Buy $126.00 to $161.00
2015-06-23 Initiated Coverage RBC Capital Outperform $159.00
2015-06-05 Reiterated Rating Susquehanna Positive $145.00 to $150.00
2015-05-05 Reiterated Rating Cantor Fitzgerald Hold $115.00
2015-04-17 Boost Price Target Barclays Overweight $138.00 to $140.00
2015-04-17 Boost Price Target Oppenheimer Outperform $128.00 to $133.00
2015-04-17 Initiated Coverage Mizuho Buy $140.00 to $146.00
2015-04-13 Upgrade Jefferies Group Hold to Buy $119.00 to $141.00
2015-04-07 Boost Price Target Deutsche Bank Buy $131.00 to $133.00
2015-04-07 Boost Price Target Deutsche Bank AG Buy $131.00 to $133.00
2015-03-31 Boost Price Target Leerink Swann Outperform $130.00 to $135.00
2015-03-31 Upgrade Credit Suisse Outperform $120.00 to $135.00
2015-03-31 Initiated Coverage FBR & Co. Outperform $120.00 to $130.00
2015-03-25 Initiated Coverage Mizuho Buy $140.00
2015-03-20 Boost Price Target Barclays Overweight $124.00 to $138.00
2015-03-06 Boost Price Target Deutsche Bank Buy to Buy $119.00 to $127.00
2015-03-06 Upgrade Sterne Agee CRT Underperform to Neutral $105.00 to $126.00
2015-03-05 Boost Price Target Piper Jaffray Overweight $121.00 to $149.00
2015-01-22 Reiterated Rating Cantor Fitzgerald Hold $105.00
2015-01-22 Boost Price Target Oppenheimer Outperform $108.00 to $115.00
2015-01-16 Downgrade Goldman Sachs Buy to Neutral
2015-01-08 Boost Price Target Barclays Overweight $110.00 to $117.00
2015-01-07 Downgrade Goldman Sachs Buy to Neutral $113.00 to $109.00
2015-01-06 Reiterated Rating Deutsche Bank Buy $105.00 to $115.00
2014-12-03 Boost Price Target Cantor Fitzgerald Hold $95.00 to $100.00
2014-12-03 Boost Price Target Credit Suisse Outperform $95.00 to $110.00
2014-12-03 Boost Price Target Oppenheimer Outperform $94.00 to $108.00
2014-12-03 Boost Price Target Stifel Nicolaus Buy $95.00 to $110.00
2014-12-03 Boost Price Target FBR & Co. Outperform $95.00 to $110.00
2014-11-18 Boost Price Target Bank of America Buy $102.00 to $112.00
2014-11-18 Boost Price Target Bank of America Corp. Buy $102.00 to $112.00
2014-10-17 Reiterated Rating Jefferies Group Hold $87.00 to $93.00
2014-10-17 Reiterated Rating Citigroup Inc. Neutral $77.00 to $86.00
2014-10-17 Reiterated Rating Barclays Overweight $99.00 to $101.00
2014-10-17 Upgrade Leerink Swann Market Perform to Outperform $100.00
2014-10-06 Initiated Coverage Piper Jaffray Overweight $121.00
2014-08-07 Downgrade Goldman Sachs Conviction-Buy to Buy
2014-07-21 Reiterated Rating Sterne Agee CRT Underperform $80.00 to $87.00
2014-07-18 Reiterated Rating Raymond James Strong-Buy $87.00 to $98.00
2014-07-18 Boost Price Target Deutsche Bank $95.00
2014-07-18 Reiterated Rating Credit Suisse Outperform $82.00 to $95.00
2014-07-18 Boost Price Target Oppenheimer Outperform $84.00 to $94.00
2014-07-18 Boost Price Target Barclays Overweight $84.00 to $99.00
2014-07-17 Boost Price Target FBR & Co. Outperform $85.00 to $95.00
2014-07-16 Reiterated Rating Deutsche Bank Buy $92.00 to $95.00
2014-07-15 Boost Price Target Cowen and Company $85.00 to $91.00
2014-07-14 Boost Price Target Susquehanna $94.00 to $96.00
2014-07-10 Downgrade Jefferies Group Buy to Hold $87.00
2014-06-27 Initiated Coverage Sterne Agee CRT Sell to Underperform $80.00
2014-04-21 Boost Price Target CRT Capital Buy $80.00 to $90.00
2014-04-21 Lower Price Target Deutsche Bank Buy $90.00 to $85.00
2014-04-21 Lower Price Target Jefferies Group Buy $89.00 to $87.00
2014-04-21 Boost Price Target Leerink Swann Market Perform $77.00 to $79.00
2014-04-16 Downgrade Citigroup Inc. Buy to Neutral $79.00
2014-04-15 Reiterated Rating Cantor Fitzgerald Hold $80.00
2014-04-10 Boost Price Target Susquehanna $82.00 to $94.00
2014-04-03 Boost Price Target Deutsche Bank Buy $85.00 to $90.00
2014-03-07 Boost Price Target Jefferies Group $89.00
2014-01-22 Reiterated Rating Morgan Stanley Overweight
2014-01-21 Downgrade Monness Crespi & Hardt Neutral to Sell $59.00
2014-01-16 Boost Price Target FBR & Co. Outperform $77.00 to $85.00
2014-01-13 Reiterated Rating Morgan Stanley Overweight
2014-01-07 Upgrade Deutsche Bank Hold to Buy $74.00 to $85.00
2013-12-04 Boost Price Target JPMorgan Chase & Co. $84.00 to $87.00
2013-12-04 Reiterated Rating Jefferies Group Buy $82.00 to $86.00
2013-11-21 Initiated Coverage Morgan Stanley Overweight $84.00
2013-11-20 Boost Price Target JPMorgan Chase & Co. Overweight $80.00 to $84.00
2013-11-18 Initiated Coverage Leerink Swann Market Perform $77.00
2013-11-13 Initiated Coverage FBR & Co. Outperform
2013-11-05 Downgrade Monness Crespi & Hardt Buy to Neutral
2013-10-18 Downgrade Cantor Fitzgerald Buy to Hold
2013-10-16 Boost Price Target Deutsche Bank Hold $71.00 to $78.00
2013-10-14 Boost Price Target Monness Crespi & Hardt $75.00 to $77.00
2013-10-09 Reiterated Rating Susquehanna Positive $81.00 to $84.00
2013-10-08 Boost Price Target Deutsche Bank Hold $68.00 to $71.00
2013-09-30 Downgrade Ned Davis Research Buy to Neutral
2013-09-24 Boost Price Target JPMorgan Chase & Co. Overweight $70.00 to $80.00
2013-07-16 Reiterated Monness Crespi & Hardt Buy $68 to $75
2013-04-02 Reiterated Cantor Fitzgerald Buy $63 to $70
2013-02-21 Upgrade Oppenheimer Perform to Outperform $63 to $66
2016-06-29 Reiterated Rating Credit Suisse Buy $148.00
2016-06-29 Reiterated Rating Credit Suisse Group AG Buy $148.00
2016-06-28 Initiated Coverage Wolfe Research Outperform $172.00
2016-06-27 Reiterated Rating Leerink Swann Buy
2016-06-15 Initiated Coverage Sanford C. Bernstein Outperform $171.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
BURKE RICHARD T 0.18%  (1761533) FCFS / MTH / UNH /
HEMSLEY STEPHEN J President & Chief Exec Officer 0.16%  (1548019) UNH /
LEATHERDALE DOUGLAS W 0.09%  (921644) UNH /
WICHMANN DAVID S EVP & CFO, Pres UHG Operations 0.08%  (805117) TNC / UNH /
Bueno Edson de Godoy 0.02%  (207817) UNH /
BOUDREAUX GAIL EVP & CEO, UnitedHealthcare 0.02%  (184731) NVAX / UNH / WLP / XEL / ZMH /
RENFRO LARRY C EVP, UHG and CEO, Optum 0.02%  (173330) UNH /
SHORT MARIANNE D EVP & Chief Legal Officer 0.01%  (101223) UNH /
RENWICK GLENN M 0.01%  (79066) FISV / PGR / UNH /
BALLARD WILLIAM C JR 0.01%  (71913) HCN / UNH /
REX JOHN F EVP Chief Financial Officer 0.01%  (70726) UNH /
WILENSKY GAIL R 0.01%  (56677) DGX / UNH /
DARRETTA ROBERT J 0.01%  (54480) UNH /